Neurotoxicity of zearalenone's metabolites and beauvericin mycotoxins via apoptosis and cell cycle disruption.
Beauvericin
Cell cycle
Cell death
Neuronal cells
Zearalenone’s metabolites
Journal
Toxicology
ISSN: 1879-3185
Titre abrégé: Toxicology
Pays: Ireland
ID NLM: 0361055
Informations de publication
Date de publication:
30 05 2021
30 05 2021
Historique:
received:
27
01
2021
revised:
18
03
2021
accepted:
12
04
2021
pubmed:
20
4
2021
medline:
23
6
2021
entrez:
19
4
2021
Statut:
ppublish
Résumé
Cell cycle progression and programmed cell death are imposed by pathological stimuli of extrinsic or intrinsic including the exposure to neurotoxins, oxidative stress and DNA damage. All can cause abrupt or delayed cell death, inactivate normal cell survival or cell death networks. Nevertheless, the mechanisms of the neuronal cell death are unresolved. One of the cell deaths triggers which have been wildly studied, correspond to mycotoxins produced by Fusarium species, which have been demonstrated cytotoxicity and neurotoxicity through impairing cell proliferation, gene expression and induction of oxidative stress. The aim of present study was to analyze the cell cycle progression and cell death pathway by flow cytometry in undifferentiated SH-SY5Y neuronal cells exposed to α-zearalenol (α-ZEL), β-zearalenol (β-ZEL) and beauvericin (BEA) over 24 h and 48 h individually and combined at the following concentration ranges: from 1.56 to 12.5 μM for α-ZEL and β-ZEL, from 0.39 to 2.5 μM for BEA, from 1.87 to 25 μM for binary combinations and from 3.43 to 27.5 μM for tertiary combination. Alterations in cell cycle were observed remarkably for β-ZEL at the highest concentration in all treatments where engaged (β-ZEL, β-ZEL + BEA and β-ZEL + α-ZEL), for both 24 h and 48 h. by activating the cell proliferation in G0/G1 phase (up to 43.6 %) and causing delays or arrests in S and G2/M phases (up to 19.6 %). Tertiary mixtures revealed increases of cell proliferation in subG0 phase by 4-folds versus control. Similarly, for cell death among individual treatments β-ZEL showed a significant growth in early apoptotic cells population at the highest concentration assayed as well as for all combination treatments where β-ZEL was involved, in both early apoptotic and apoptotic/necrotic cell death pathways.
Identifiants
pubmed: 33872728
pii: S0300-483X(21)00107-4
doi: 10.1016/j.tox.2021.152784
pii:
doi:
Substances chimiques
Depsipeptides
0
Estrogens, Non-Steroidal
0
Mycotoxins
0
beauvericin
26S048LS2R
Zearalenone
5W827M159J
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
152784Informations de copyright
Copyright © 2021 Elsevier B.V. All rights reserved.